CHF and Arrhythmias

PRADAXA (dabigatran etexilate) 75mg, 150mg capsules by Boehringer Ingelheim

Pradaxa approved for stroke risk reduction

Boehringer Ingelheim announced that the FDA has approved Pradaxa (dabigatran etexilate capsules), an oral direct thrombin inhibitor, to reduce the risk of stroke and systemic embolism in patients with non-valvular atrial fibrillation (AFib).

FDA warns against Que She herbal supplement

The FDA has warned consumers and healthcare professionals that Que She, marketed as “Slimming Factor Capsule,” an herbal weight loss supplement, contains undeclared ingredients that could harm consumers, especially those with cardiovascular conditions.

FDA Video: New Warnings on Norpramin

Use extreme caution when giving this drug to patients with a family history of sudden death, cardiac dysrhythmias, and cardiac conduction disturbances.